A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.

Systems, methods and apparatuses for aerosolizing all or substantially all plant matter, medications, flavors, smells, liquid and/or other material to be aerosolizing are disclosed. Embodiments of the invention comprise an aerosolization chamber sealed except for two or more conduits, a first conduit coupled to a source of fully or almost fully oxygenated gas, a heating element capable of heating the aerosolization chamber to a temperature above a combustion temperature, a second conduit configured to transport aerosolized gases and elements out of the chamber and, in one implementation, at least one valve positioned in the second conduit preventing the flow of atmospheric air into the vaporization chamber. In some instances, the first gas substantially clears the vaporization chamber of atmospheric air prior to reaching combustion temperature. A second gas containing oxygen may be intermixed with the vaporization gases and vaporized elements proximal to the combustion chamber.

A device for improving cognitive and functional capabilities by means of hypoxic and hyperoxic gas mixtures. An air splitter (5) separates oxygen and nitrogen and feeds these gases to a mixer (4), whose mixing rate is determined by feed back from a bio feedback regulator and an oximeter. The oximeter is connected to a finger piece sensor or pulse meter, and/or an ear-piece sensor for receiving inpute from a patient. The gas mixer feeds an adjusted oxygen and nitrogen mixture to the patient by way of a mouthpiece connected to the mixer.

A breathing device, comprising a mouthpiece forming a breathing channel, to form a connection between a first end and a second end of the mouthpiece; the first end being configured for a user breathing into the mouthpiece through a breathing opening; an at least partly flexible rebreathing air chamber attached to the second end of the mouthpiece, thereby being in fluid connection with the breathing channel; the rebreathing air chamber being formed by at least partly flexible wall section(s), the at least partly flexible rebreathing chamber having at a first wall section, being permeable to gas by a plurality of pores provided in said wall section and/or the mouth piece comprising one or more though going openings.

A hood for a sterilization system including a return line (132) to provide for airflow between first and second ends; a hood (116) having an opening situated in a top wall and configured to be coupled to a tube; and couplers (126) configured to couple the hood to adjacent ones of a plurality of support struts (114) to configure the hood to form an opening (128) leading to a cavity (129), wherein the cavity is configured to receive at least a portion of a head of a subject (101) receiving respiratory gas from a ventilator (170) such that the plurality of support struts are situated outside of the cavity, wherein the hood is configured to enable ambient air into the airflow while over the portion of the head of the subject.

Systems and methods for hypoxia delivery are provided. An apparatus for providing intermittent normoxia and hypoxia intervals includes a breathing component, a normoxia fluid source, a hypoxia fluid source, a valve, and a control system. The valve is configured to disrupt flow from at least one of the normoxia fluid source and the hypoxia fluid source and the control system is configured to cause the at least one valve to switch between delivery of fluid from the normoxia fluid source and the hypoxia fluid source while maintaining positive pressure at the breathing component.

The present invention pertains to a system, method, and device for treating sleep disorders. The present invention is particularly useful in the delivery of carbon dioxide (CO2) to a subject and in the treatment of sleep apnea. Furthermore, integration of components with various sensors and apparatuses associated therewith and attached thereto preferably complete a rebreathing circuit in the present invention. In various embodiments of the present invention where the above components are integrated as a rebreathing circuit, a subject is both the source and recipient of a controlled concentration of carbon dioxide. In such embodiments, treatment of sleep disorders becomes much more efficient and effective.

This document provides methods and materials for treating hypocapnia. For example, methods and materials for delivering CO.sub.2 to a mammal to treat hypocapnia or compensate for a reduced level of CO.sub.2 are provided.

An anesthetic gas delivery system includes a gas machine for supplying anesthetic gas to a patient; a scavenging control system that controls a level of vacuum suction to evacuate waste anesthetic gas; and a user interface electronically coupled to the scavenging control system. The scavenging control system includes an air flow sensor external from the gas machine that measures the flow rate of the waste anesthetic gas through the scavenging control system; a control valve, such as a proportional solenoid valve, that is controllable to adjust the level of vacuum suction to adjust the flow rate of the waste anesthetic gas; and electronic control circuitry that is configured to receive a measured flow rate from the sensor and to control the control valve to adjust the level of vacuum suction based on the flow rate measured by the sensor. The electronic control circuitry further is configured to transmit flow rate information corresponding to the flow rate measured by the sensor to the user interface.

Provided are methods and devices useful for treating a respiratory disease or disorder involving the central or upper airways. The methods and devices deliver to central or upper airways of a subject a vapor or aerosol comprising an effective amount of an active ingredient selected from the group consisting of menthol, menthone, neomenthol, isomenthol, and menthofuran. The methods are useful for treating conditions including cough, asthma, bronchitis, and allergic rhinitis.